In the latest episode of Paul Talks Science, we go inside the labs — and into the field — with Oxitec, the biotech company developing and deploying genetically modified mosquitoes to combat malaria in Djibouti.
Paul speaks with Oxitec CEO Grey Frandsen about how their “friendly males” are being used in Djibouti to target Anopheles stephensi, a fast-spreading mosquito that’s driving malaria into African cities. They unpack the science, the skepticism, and the scale of ambition behind this cutting-edge vector control effort.
This isn’t science fiction. It’s one of the most promising — and controversial — innovations in global public health.
📖 Read the full story in Nature Medicine: Battle of the Mosquitoes